Showing results 2 to 4 of 4
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Improvement of drug efficacy of polo-like kinase 4 inhibitor in the treatment of uterine leiomyosarcoma Proceeding/Conference:Cancer Research | 2020 | ||
PLK4 inhibitor suppresses hepatocellular carcinoma (HCC) through inducing extensive polyploidy and activating STING pathway Proceeding/Conference:EMBO Workshop: Cell death in immunity and inflammation | 2019 | ||
2022 |